old myth of curing hepc with antisense, page-35

Supermajor,

unfortunately its not for you, for me or even patient groups to decide on how to price the drug. And while I would be happy to see the drug given cheap... the price will be decided purely out of non-altruistic view.

Some smart guys on buy-side at Wall-Street (some of those that are getting placement now) will build their models on what price will drive the best P/E growth given particular number of eligible patients and number of injections.

And the company will be largely driven and guided by the Street on what price to put.

And given the promise of one shot cure, the smart guy will probably price at $200K -$300K at least, depending on cure rates.

And if the cure rates are below sofosbuvir's and AbbVie's new pill combo in Phase III now.... Benitec will sell none